← Leaderboards
Shilpa Sharma
Va Greater Los Angeles Healthcare System
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2021–24$1$1$1$0$0
'21
'22
'23
'24
Funding mix
By agency
VA$0 · 1
By mechanism
IK2$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Va Greater Los Angeles Healthcare System
Same institution · by research overlap
- Anna S Gukovskaya$6,581,112
- Karl Lorenz$1,403,593
- Lena F Reddy$0
Others in their field
Other Emerging Leaders on “Chronic Kidney Failure”
- Vera Hoffman · Reveal Pharma$11,205,165
- Kirsten Johansen · Hennepin Healthcare Research Institute$9,776,955
- Derek K Ng · Johns Hopkins University$8,188,378
- Marlena Habal · Columbia University Health Sciences$5,428,816
- Manisha Jhamb · University Of Pittsburgh At Pittsburgh$5,386,980
- Alex Hughes · University Of Pennsylvania$5,126,320
Research focus
Chronic Kidney FailureAffinityAcuteAffectApplications GrantsAreaAwardAmericanBiological MarkersBiometryBloodBone DiseasesBrain Hypoxia-IschemiaCardiovascular CollapseCardiovascular DiseasesCardiovascular ImagingCardiovascular SystemCareerCareer DevelopmentCause Of DeathCell MembraneCellular BiologyCessation Of LifeClinical Investigation
Grant awards (4)
Dynamic Changes in Erythrocyte 2,3 DPG as a Driver of Cardiac Dysfunction in End Stage Kidney Disease$0
IK2 · FY2024 · VA · contact PI
Dynamic Changes in Erythrocyte 2,3 DPG as a Driver of Cardiac Dysfunction in End Stage Kidney Disease$0
IK2 · FY2023 · VA · contact PI
Dynamic Changes in Erythrocyte 2,3 DPG as a Driver of Cardiac Dysfunction in End Stage Kidney Disease$0
IK2 · FY2022 · VA · contact PI
Dynamic Changes in Erythrocyte 2,3 DPG as a Driver of Cardiac Dysfunction in End Stage Kidney Disease$0
IK2 · FY2021 · VA · contact PI